tiprankstipranks
AbbVie (ABBV)
NYSE:ABBV
Holding ABBV?
Track your performance easily

AbbVie (ABBV) Technical Analysis

21,600 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
AbbVie’s (ABBV) Moving Averages Convergence Divergence (MACD) indicator is -6.92, suggesting AbbVie is a Buy.
AbbVie’s (ABBV) 20-Day exponential moving average is 180.07, while AbbVie’s (ABBV) share price is $176.19, making it a Sell.
AbbVie’s (ABBV) 50-Day exponential moving average is 185.65, while AbbVie’s (ABBV) share price is $176.19, making it a Sell.

AbbVie (ABBV) Pivot Points

Nov 22, 2024, 02:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
164.04
164.85
166.30
167.11
168.56
169.37
170.82
Fibonacci
164.85
165.71
166.24
167.11
167.97
168.50
169.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (ABBV) Moving Averages

Nov 22, 2024, 02:19 PM
Period
Simple
Exponential
MA5
167.47Buy
169.73Buy
MA10
172.23Sell
173.71Sell
MA20
185.10Sell
180.07Sell
MA50
189.12Sell
185.65Sell
MA100
186.54Sell
183.92Sell
MA200
176.47Sell
175.56Sell
AbbVie’s (ABBV) 10-Day exponential moving average is 173.71, while AbbVie’s (ABBV) share price is $176.19, making it a Sell.
AbbVie’s (ABBV) 100-Day exponential moving average is 183.92, while AbbVie’s (ABBV) share price is $176.19, making it a Sell.
AbbVie’s (ABBV) stock price is $176.19 and AbbVie’s (ABBV) 50-day simple moving average is 189.12, creating a Sell signal.
AbbVie’s (ABBV) stock price is $176.19 and AbbVie’s (ABBV) 100-day simple moving average is 186.54, creating a Sell signal.
AbbVie’s (ABBV) stock price is $176.19 and AbbVie’s (ABBV) 200-day simple moving average is 176.47, creating a Sell signal.

AbbVie (ABBV) Technical Indicators

Nov 22, 2024, 02:19 PM
Name
Value
Implied Action
RSI (14)
35.17
Neutral
STOCH (9,6)
23.73
Neutral
STOCHRSI (14)
11.46
Buy
MACD (12,26)
-6.92
Buy
ADX (14)
35.54
Neutral
Williams %R
-81.29
Buy
CCI (14)
-69.55
Neutral
ATR (14)
4.64
-
Ultimate Oscillator
44.53
Neutral
ROC
-15.63
Sell
AbbVie’s (ABBV) Relative Strength Index (RSI) is 35.17, creating a Neutral signal.
AbbVie’s (ABBV) Trend Strength Indicator (ADX) is 35.54, creating a Neutral signal.
AbbVie’s (ABBV) Commodity Channel Index (CCI) is -69.55, creating a Neutral signal.
AbbVie’s (ABBV) Price Rate of Change (ROC) is -15.63, creating a Sell signal.

FAQ

Is ABBV a Buy, Hold, or Sell?
Based on ABBV’s technical indicators, ABBV is a Sell.
    What is ABBV’s RSI (14)?
    ABBV’s RSI (14) is 35.17, which suggests ABBV is a Neutral.
      What is ABBV’s MACD?
      ABBV’s MACD is -6.92, which suggests ABBV is a Buy.
        What is ABBV’s 5-day moving average?
        ABBV’s 5-day moving average is 167.47, which suggests ABBV is a Buy.
          What is ABBV’s 20-day moving average?
          ABBV 20-day moving average is 185.10, which suggests ABBV is a Sell.
            What is ABBV’s 50-day moving average?
            ABBV’s 50-day moving average is 189.12, which suggests ABBV is a Sell.
              What is ABBV’s 200-day moving average?
              ABBV’s 200-day moving average is 176.47, which suggests ABBV is a Sell.
                What is ABBV’s Williams % R (14)?
                ABBV’s Williams % R (14) is -81.29, which suggests ABBV is a Buy.
                  What is ABBV’s CCI (14)?
                  ABBV’s CCI (14) is -69.55, which suggests ABBV is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis